Clinical Trials Browser

Interventional × anetumab ravtansine × Gastrointestinal × Clear all

NCT03102320 2022-06-30

ARCS-Multi

Phase 1 Completed

BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Thymoma, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT03023722 2021-10-28

Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer

Phase 2 Completed

18 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms